News
-
-
-
COMMUNIQUÉ DE PRESSE
EQS-Adhoc: Takeda Pharmaceutical Company Limited: Takeda Announces Next Steps in its Transformation to Strengthen Competitiveness and Accelerate Future Growth Outlook
Takeda announces next steps in its transformation to strengthen competitiveness and accelerate future growth outlook, positioning the company for its next era -
-
-
-
-
-
COMMUNIQUÉ DE PRESSE
EQS-Adhoc: Takeda Pharmaceutical Company Limited: Julie Kim Will Succeed Christophe Weber as CEO of Takeda in June 2026
Julie Kim to succeed Christophe Weber as CEO of Takeda in June 2026. Board unanimously appoints her to lead after Weber's 12 successful years. Succession process concluded -